Melanoma Clinical Trials in Houston

Showing 241-260 of 268 trials

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

NCT00004025

RATIONALE: Vaccines made from a person's white blood cells combined with melanoma antigens may make the body build an immune response to tumor cells. Interleukin-2 may stimulate a person's white blood cells to kill melanoma cells. Combining vaccine therapy with interleukin-2 may be an effective treatment for stage III or stage IV melanoma. PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy with or without interleukin-2 in treating patients who have stage III or stage IV melanoma that cannot be surgically removed.

Melanoma (Skin)

Genzyme, a Sanofi Company36 participantsStarted Mar 1999

Boston, Massachusetts, United States • Houston, Texas, United States

UNKNOWNPhase 2< 1 mile

Vaccine Therapy in Treating Patients With Malignant Melanoma

NCT00128583

RATIONALE: Vaccines made from tumor cells may help the body build an effective immune response to kill tumor cells. PURPOSE: This phase II trial is studying vaccine therapy to see how well it works in treating patients with malignant melanoma.

Melanoma (Skin)

CancerVax CorporationStarted Jul 2005

Palm Springs, California, United States • Santa Monica, California, United States • Lakeland, Florida, United States +8 more locations

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Vaccine Therapy in Treating Patients With Malignant Melanoma

Melanoma Trials in Other Cities

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

Body Image Functioning Among Surgically Treated Patients With Head and Neck Cancer

Evaluating the Use of Fibrin Tissue Adhesive in Melanoma Patients

CP-675,206 In Patients With Advanced Melanoma

Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

Study of CP-675,206 in Refractory Melanoma

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma

Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

Other Conditions in Houston